ISRAEL AT WAR - DAY 65

search

Facebook to remove misinformation about COVID vaccine

LONDON — Facebook says it will start removing false claims about COVID-19 vaccines, in its latest move to counter a tide of coronavirus-related online misinformation.

In the coming weeks, the social network will begin taking down any Facebook or Instagram posts with false information about the vaccines that have been debunked by public health experts.

The US tech giant is taking action as the first COVID-19 vaccines are set to be rolled out. Britain this week became the first country to give emergency authorization for a vaccine developed by American drugmaker Pfizer and Germany’s BioNTech, and inoculations could start within days. Regulators in the US, the European Union and Canada are also vetting vaccines.

Facebook says it’s applying a policy to remove virus misinformation that could lead to “imminent physical harm.”

Posts that fall afoul of the policy could include phony claims about vaccine safety, efficacy, ingredients or side effects.

“For example, we will remove false claims that COVID-19 vaccines contain microchips, or anything else that isn’t on the official vaccine ingredient list,” the company says in a blog post.

Conspiracy theories about the vaccines that are already known to be false will also be removed.

Facebook has taken other steps to try to stop the spread of vaccine and coronavirus-related misinformation on its platform. From March to October, it has removed 12 million posts with coronavirus-related misinformation. The deleted posts include one by President Donald Trump with a link to a Fox News video of him saying children are “virtually immune” to the virus.

In October, the company banned ads discouraging vaccinations, though it made an exception for advocacy ads about government vaccine policies. The company has also promoted articles debunking COVID-19 misinformation on an information center.

— AP

Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering also lets you comment on articles and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.